Abstract
Data on cardiovascular risk associated with different types of antidiabetic treatments are sparse and conflicting. We examined the risk of hospitalisation with myocardial infarction (MI) among patients treated with sulfonylureas, metformin, insulin, any combination and no antidiabetic pharmacotherapy.
Original language | English |
---|---|
Journal | Pharmacoepidemiology and Drug Safety |
Volume | 20 |
Issue number | 4 |
Pages (from-to) | 331-7 |
Number of pages | 7 |
ISSN | 1053-8569 |
DOIs | |
Publication status | Published - 1 Apr 2011 |
Externally published | Yes |